App-Based Insulin Calculators: Current and Future State

Leslie Eiland, Meghan McLarney, Thiyagarajan Thangavelu, Andjela T Drincic

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Purpose of Review: To perform a comprehensive literature review and critical assessment of peer-reviewed manuscripts addressing the efficacy, safety, or usability of insulin calculator apps. Recent Findings: Managing diabetes with insulin can be complex, and literacy and numeracy skills pose barriers to manual insulin dose calculations. App-based insulin calculators are promising tools to help people with diabetes administer insulin safely and have potential to improve glycemic control. While a large number of apps which assist with insulin dosing are available, there is limited data evaluating their efficacy, safety, and usability. Recently, a need for regulatory oversight has been recognized, but few apps meet federal standards. Thus, choosing an appropriate app is challenging for both patients and providers. An electronic literature review was performed to identify insulin calculator apps with either evidence for efficacy, safety or usability published in peer-reviewed literature or with FDA/CE approval. Twenty apps were identified intended for use by patients with diabetes on insulin. Of these, nine included insulin calculators. Summaries of each app, including pros and cons, are provided. Summary: Insulin-calculator apps have the potential to improve self-management of diabetes. While current literature demonstrates improvements in quality of life and glycemic control after use of these programs, larger trials are needed to collect outcome and safety data. Also, further human factor analysis is needed to assure these apps will be adopted appropriately by people with diabetes. App features including efficacy and safety data need to be easily available for consumer review and decision making. Higher standards need to be set for app developers to ensure safety and efficacy.

Original languageEnglish (US)
Article number123
JournalCurrent diabetes reports
Volume18
Issue number11
DOIs
StatePublished - Nov 1 2018

Fingerprint

Insulin
Safety
Manuscripts
Self Care
Statistical Factor Analysis
Decision Making
Quality of Life

Keywords

  • FDA
  • Insulin bolus calculators
  • Smartphone applications
  • Type 1 diabetes
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

App-Based Insulin Calculators : Current and Future State. / Eiland, Leslie; McLarney, Meghan; Thangavelu, Thiyagarajan; Drincic, Andjela T.

In: Current diabetes reports, Vol. 18, No. 11, 123, 01.11.2018.

Research output: Contribution to journalReview article

Eiland, Leslie ; McLarney, Meghan ; Thangavelu, Thiyagarajan ; Drincic, Andjela T. / App-Based Insulin Calculators : Current and Future State. In: Current diabetes reports. 2018 ; Vol. 18, No. 11.
@article{5781927307db4bbaa35407facfa81ccc,
title = "App-Based Insulin Calculators: Current and Future State",
abstract = "Purpose of Review: To perform a comprehensive literature review and critical assessment of peer-reviewed manuscripts addressing the efficacy, safety, or usability of insulin calculator apps. Recent Findings: Managing diabetes with insulin can be complex, and literacy and numeracy skills pose barriers to manual insulin dose calculations. App-based insulin calculators are promising tools to help people with diabetes administer insulin safely and have potential to improve glycemic control. While a large number of apps which assist with insulin dosing are available, there is limited data evaluating their efficacy, safety, and usability. Recently, a need for regulatory oversight has been recognized, but few apps meet federal standards. Thus, choosing an appropriate app is challenging for both patients and providers. An electronic literature review was performed to identify insulin calculator apps with either evidence for efficacy, safety or usability published in peer-reviewed literature or with FDA/CE approval. Twenty apps were identified intended for use by patients with diabetes on insulin. Of these, nine included insulin calculators. Summaries of each app, including pros and cons, are provided. Summary: Insulin-calculator apps have the potential to improve self-management of diabetes. While current literature demonstrates improvements in quality of life and glycemic control after use of these programs, larger trials are needed to collect outcome and safety data. Also, further human factor analysis is needed to assure these apps will be adopted appropriately by people with diabetes. App features including efficacy and safety data need to be easily available for consumer review and decision making. Higher standards need to be set for app developers to ensure safety and efficacy.",
keywords = "FDA, Insulin bolus calculators, Smartphone applications, Type 1 diabetes, Type 2 diabetes",
author = "Leslie Eiland and Meghan McLarney and Thiyagarajan Thangavelu and Drincic, {Andjela T}",
year = "2018",
month = "11",
day = "1",
doi = "10.1007/s11892-018-1097-y",
language = "English (US)",
volume = "18",
journal = "Current Diabetes Reports",
issn = "1534-4827",
publisher = "Current Medicine Group",
number = "11",

}

TY - JOUR

T1 - App-Based Insulin Calculators

T2 - Current and Future State

AU - Eiland, Leslie

AU - McLarney, Meghan

AU - Thangavelu, Thiyagarajan

AU - Drincic, Andjela T

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Purpose of Review: To perform a comprehensive literature review and critical assessment of peer-reviewed manuscripts addressing the efficacy, safety, or usability of insulin calculator apps. Recent Findings: Managing diabetes with insulin can be complex, and literacy and numeracy skills pose barriers to manual insulin dose calculations. App-based insulin calculators are promising tools to help people with diabetes administer insulin safely and have potential to improve glycemic control. While a large number of apps which assist with insulin dosing are available, there is limited data evaluating their efficacy, safety, and usability. Recently, a need for regulatory oversight has been recognized, but few apps meet federal standards. Thus, choosing an appropriate app is challenging for both patients and providers. An electronic literature review was performed to identify insulin calculator apps with either evidence for efficacy, safety or usability published in peer-reviewed literature or with FDA/CE approval. Twenty apps were identified intended for use by patients with diabetes on insulin. Of these, nine included insulin calculators. Summaries of each app, including pros and cons, are provided. Summary: Insulin-calculator apps have the potential to improve self-management of diabetes. While current literature demonstrates improvements in quality of life and glycemic control after use of these programs, larger trials are needed to collect outcome and safety data. Also, further human factor analysis is needed to assure these apps will be adopted appropriately by people with diabetes. App features including efficacy and safety data need to be easily available for consumer review and decision making. Higher standards need to be set for app developers to ensure safety and efficacy.

AB - Purpose of Review: To perform a comprehensive literature review and critical assessment of peer-reviewed manuscripts addressing the efficacy, safety, or usability of insulin calculator apps. Recent Findings: Managing diabetes with insulin can be complex, and literacy and numeracy skills pose barriers to manual insulin dose calculations. App-based insulin calculators are promising tools to help people with diabetes administer insulin safely and have potential to improve glycemic control. While a large number of apps which assist with insulin dosing are available, there is limited data evaluating their efficacy, safety, and usability. Recently, a need for regulatory oversight has been recognized, but few apps meet federal standards. Thus, choosing an appropriate app is challenging for both patients and providers. An electronic literature review was performed to identify insulin calculator apps with either evidence for efficacy, safety or usability published in peer-reviewed literature or with FDA/CE approval. Twenty apps were identified intended for use by patients with diabetes on insulin. Of these, nine included insulin calculators. Summaries of each app, including pros and cons, are provided. Summary: Insulin-calculator apps have the potential to improve self-management of diabetes. While current literature demonstrates improvements in quality of life and glycemic control after use of these programs, larger trials are needed to collect outcome and safety data. Also, further human factor analysis is needed to assure these apps will be adopted appropriately by people with diabetes. App features including efficacy and safety data need to be easily available for consumer review and decision making. Higher standards need to be set for app developers to ensure safety and efficacy.

KW - FDA

KW - Insulin bolus calculators

KW - Smartphone applications

KW - Type 1 diabetes

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85054435051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054435051&partnerID=8YFLogxK

U2 - 10.1007/s11892-018-1097-y

DO - 10.1007/s11892-018-1097-y

M3 - Review article

C2 - 30284645

AN - SCOPUS:85054435051

VL - 18

JO - Current Diabetes Reports

JF - Current Diabetes Reports

SN - 1534-4827

IS - 11

M1 - 123

ER -